Global Blood Therapeutics Inc. (NASDAQ:GBT) saw a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 3,509,680 shares, a decrease of 36.5% from the June 30th total of 5,529,527 shares. Approximately 18.6% of the company’s stock are short sold. Based on an average daily trading […]
